Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C15H23NO2.ClH |
Molecular Weight | 285.81 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.[H][C@@]1(CCCC[C@H]1O)[C@@H](N(C)C)C2=CC=CC(O)=C2
InChI
InChIKey=XBNIHQOJYIOGEU-HWKASLJMSA-N
InChI=1S/C15H23NO2.ClH/c1-16(2)15(11-6-5-7-12(17)10-11)13-8-3-4-9-14(13)18;/h5-7,10,13-15,17-18H,3-4,8-9H2,1-2H3;1H/t13-,14+,15-;/m0./s1
Molecular Formula | C15H23NO2 |
Molecular Weight | 249.3486 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Ciramadol is an opioid agonist-antagonist analgesic with low potential for dependency. Ciramadol appears to be an effective analgesic, with tolerable gastrointestinal central nervous system side effects at both the 30-and 90-mg dose levels. Ciramadol is a mixed agonist-antagonist for the μ-opioid receptor. Side effects might include nausea and vomiting.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3753988
Curator's Comment: Intramuscular route is also possible: Efficacy and safety of the analgesic ciramadol in the management of postoperative pain was evaluated in 139 healthy patients given single, double-blind, intramuscular injections of either 30 mg ciramadol, 60 mg ciramadol, 10 mg morphine or 0.9% saline on the first or second postoperative day. During the first hour after administration, some measurements showed that 30 mg ciramadol was superior to 60 mg ciramadol. https://www.ncbi.nlm.nih.gov/pubmed/6348105
Ciramadol was compared in 30 and 60 mg doses with pentazocine 50 mg, aspirin 650 mg, and placebo in the treatment of 153 patients with postoperative pain. All drugs were administered between six and 72 hours after surgery. Analgesic efficacy was assessed for six hours after study drug administration using verbal pain intensity, analog pain intensity, and verbal pain relief scales. Significantly higher analgesic efficacy scores were seen with ciramadol 30 mg than with pentazocine 50 mg and placebo at most of the evaluation points. Doses of ciramadol 30 mg were significantly more effective than aspirin 650 mg at several time periods, and ciramadol 60 mg was better than pentazocine and placebo at several evaluation times. The 30-mg dose of ciramadol was generally more effective than the 60-mg dose.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:11:54 GMT 2023
by
admin
on
Fri Dec 15 15:11:54 GMT 2023
|
Record UNII |
090XO8449J
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C67413
Created by
admin on Fri Dec 15 15:11:54 GMT 2023 , Edited by admin on Fri Dec 15 15:11:54 GMT 2023
|
||
|
NCI_THESAURUS |
C1506
Created by
admin on Fri Dec 15 15:11:54 GMT 2023 , Edited by admin on Fri Dec 15 15:11:54 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C65334
Created by
admin on Fri Dec 15 15:11:54 GMT 2023 , Edited by admin on Fri Dec 15 15:11:54 GMT 2023
|
PRIMARY | |||
|
DTXSID40979443
Created by
admin on Fri Dec 15 15:11:54 GMT 2023 , Edited by admin on Fri Dec 15 15:11:54 GMT 2023
|
PRIMARY | |||
|
W-77
Created by
admin on Fri Dec 15 15:11:54 GMT 2023 , Edited by admin on Fri Dec 15 15:11:54 GMT 2023
|
PRIMARY | |||
|
63323-46-6
Created by
admin on Fri Dec 15 15:11:54 GMT 2023 , Edited by admin on Fri Dec 15 15:11:54 GMT 2023
|
PRIMARY | |||
|
264-099-4
Created by
admin on Fri Dec 15 15:11:54 GMT 2023 , Edited by admin on Fri Dec 15 15:11:54 GMT 2023
|
PRIMARY | |||
|
m653
Created by
admin on Fri Dec 15 15:11:54 GMT 2023 , Edited by admin on Fri Dec 15 15:11:54 GMT 2023
|
PRIMARY | Merck Index | ||
|
C018273
Created by
admin on Fri Dec 15 15:11:54 GMT 2023 , Edited by admin on Fri Dec 15 15:11:54 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104132
Created by
admin on Fri Dec 15 15:11:54 GMT 2023 , Edited by admin on Fri Dec 15 15:11:54 GMT 2023
|
PRIMARY | |||
|
090XO8449J
Created by
admin on Fri Dec 15 15:11:54 GMT 2023 , Edited by admin on Fri Dec 15 15:11:54 GMT 2023
|
PRIMARY | |||
|
44462
Created by
admin on Fri Dec 15 15:11:54 GMT 2023 , Edited by admin on Fri Dec 15 15:11:54 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |